Disappearing liver metastases from colorectal cancer: Impact of modern imaging modalities

HPB

Volumn 17, Issue 11, 2015, Pages 983-987

  Sturesson, Christian ^a   Nilsson, Jan ^a   Lindell, Gert ^a   Andersson, Roland G ^a   Keussen, Inger ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID; IRINOTECAN; OXALIPLATIN; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; CONTRAST ENHANCEMENT; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE ECHOGRAPHY; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TIME TO TREATMENT; TREATMENT INDICATION; ADJUVANT CHEMOTHERAPY; COLON RESECTION; COLORECTAL NEOPLASMS; COMPUTER ASSISTED SURGERY; DIAGNOSTIC IMAGING; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; LIVER NEOPLASMS; METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; PATHOLOGY; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; SECONDARY; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HEPATECTOMY; HUMANS; INJECTIONS, INTRAVENOUS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURGERY, COMPUTER-ASSISTED;

EID: 84943816142     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12476     Document Type: Article

References (22)

1. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al,. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371: 1007-1016.
2. Ye LC, Liu TS, Ren L, Wei Y, Zhu DX, Zai SY, et al,. (2013) Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. J Clin Oncol 31: 1931-1938.
3. Bischof DA, Clary BM, Maithel SK, Pawlik TM,. (2013) Surgical management of disappearing colorectal liver metastases. Br J Surg 100: 1414-1420.
4. Auer RC, White RR, Kemeny NE, Schwartz LH, Shia J, Blumgart LH, et al,. (2010) Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy. Cancer 116: 1502-1509.
5. Arita J, Ono Y, Takahashi M, Inoue Y, Takahashi Y, Saiura A,. (2014) Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy. Ann Surg Oncol 21 (Suppl 3): S390-S397.
6. van Vledder MG, de Jong MC, Pawlik TM, Schulick RD, Diaz LA, Choti MA,. (2010) Disappearing colorectal liver metastases after chemotherapy: should we be concerned? J Gastrointest Surg 14: 1691-1700.
7. Goere D, Gaujoux S, Deschamp F, Dumont F, Souadka A, Dromain C, et al,. (2011) Patients operated on for initially unresectable colorectal liver metastases with missing metastases experience a favorable long-term outcome. Ann Surg 254: 114-118.
8. Elias D, Youssef O, Sideris L, Dromain C, Baton O, Boige V, et al,. (2004) Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol 86: 4-9.
9. Ferrero A, Langella S, Russolillo N, Vigano L, Lo Tesoriere R, Capussotti L,. (2012) Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease. J Gastrointest Surg 16: 806-814.
10. Fowler KJ, Linehan DC, Menias CO,. (2013) Colorectal liver metastases: state of the art imaging. Ann Surg Oncol 20: 1185-1193.
11. Niekel MC, Bipat S, Stoker J,. (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257: 674-684.
12. Takahashi M, Hasegawa K, Arita J, Hata S, Aoki T, Sakamoto Y, et al,. (2012) Contrast-enhanced intraoperative ultrasonography using perfluorobutane microbubbles for the enumeration of colorectal liver metastases. Br J Surg 99: 1271-1277.
13. Prokop M, Galanski M, van der Molen A, Schaefer-Prokop C, eds. (2002) Spiral and multislice Computed tomography of the Body, 1st edn. Stuttgart: Georg Thieme Verlag.
14. Palmucci S,. (2014) Focal liver lesions detection and characterization: the advantages of gadoxetic acid-enhanced liver MRI. World J Hepatol 6: 477-485.
15. Macera A, Lario C, Petracchini M, Gallo T, Regge D, Floriani I, et al,. (2013) Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI sequences increases sensitivity and diagnostic accuracy. Eur Radiol 23: 739-747.
16. Kim HJ, Lee SS, Byun JH, Kim JC, Yu CS, Park SH, et al,. (2015) Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Radiology 274: 712-722.
17. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al,. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247.
18. van Kessel CS, Samim M, Koopman M, van den Bosch MA, Borel Rinkes IH, Punt CJ, et al,. (2013) Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases. Eur J Cancer 49: 2486-2493.
19. Benoist S, Nordlinger B,. (2009) The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 16: 2385-2390.
20. Ruzzenente A, Conci S, Iacono C, Valdegamberi A, Campagnaro T, Bertuzzo F, et al,. (2013) Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy. J Gastrointest Surg 17: 281-287.
21. Choti MA, Kaloma F, deOliveira ML, Nour S, Garrett-Mayer ES, Sheth S, et al,. (2008) Patient variability in intraoperative ultrasonographic characteristics of colorectal liver metastases. Arch Surg 143: 29-34; discussion 5.
22. Spelt L, Sparrelid E, Isaksson B, Andersson RG, Sturesson C,. (2015) Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases. HPB 17: 529-535.